Skip to Main Content

Author Details

David S Moss
Institute of Structural and Molecular Biology, University of London
1976
75
28
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33051680flexiMAP: a regression-based method for discovering differential alternative polyadenylation events in standard RNA-seq data.Bioinformatics2021
32109245Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein.PLoS Comput Biol2020
30266735Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A.Haematologica2019
31201325The pore structure of Clostridium perfringens epsilon toxin.Nat Commun2019
28955198Dysregulation of Alternative Poly-adenylation as a Potential Player in Autism Spectrum Disorder.Front Mol Neurosci2017
28261207Investigating Substitutions in Antibody-Antigen Complexes Using Molecular Dynamics: A Case Study with Broad-spectrum, Influenza A Antibodies.Front Immunol2017
25244644A large-scale computational study of inhibitor risk in non-severe haemophilia A.Br J Haematol2015
25227423N-linked glycans on influenza A H3N2 hemagglutinin constrain binding of host antibodies, but shielding is limited.Glycobiology2015
24187015Evolution in the influenza A H3 stalk - a challenge for broad-spectrum vaccines?J Gen Virol2014
25020226Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.J Mol Biol2014
24709588Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.Vaccine2014
24625763Identification of a key residue for oligomerisation and pore-formation of Clostridium perfringens NetB.Toxins (Basel)2014
23239883Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens.J Biol Chem2013
23504825Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.Protein Sci2013
22417279Visualisation of variable binding pockets on protein surfaces by probabilistic analysis of related structure sets.BMC Bioinformatics2012
21680505Analysis of antigenically important residues in human influenza A virus in terms of B-cell epitopes.J Virol2011
21839091Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins.J Mol Biol2011
20388627A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2.Bioinformatics2010
20439274ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale.Philos Trans A Math Phys Eng Sci2010
19487206A computational Grid framework for immunological applications.Philos Trans A Math Phys Eng Sci2009
19383844ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization.Brief Bioinform2009
19560824Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.Mol Immunol2009
17766153Toward the atomistic simulation of T cell epitopes automated construction of MHC: peptide structures for free energy calculations.J Mol Graph Model2008
18717986GPCRTree: online hierarchical classification of GPCR function.BMC Res Notes2008
18831735Towards a lightweight generic computational grid framework for biological research.BMC Bioinformatics2008
18603471Are bacterial vaccine antigens T-cell epitope depleted?Trends Immunol2008
17870168Identification of the HLA-DM/HLA-DR interface.Mol Immunol2008
16549002Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity.BMC Struct Biol2006
16749919Benchmarking pK(a) prediction.BMC Biochem2006
16893394SiPep: a system for the prediction of tissue-specific minor histocompatibility antigens.Int J Immunogenet2006
15141032A Fugu-Human Genome Synteny Viewer: web software for graphical display and annotation reports of synteny between Fugu genomic sequence and human genes.Nucleic Acids Res2004
15258571Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin.Nat Struct Mol Biol2004
14568535Clostridium absonum alpha-toxin: new insights into clostridial phospholipase C substrate binding and specificity.J Mol Biol2003
15208743A novel predictive technique for the MHC class II peptide-binding interaction.Mol Med2003
12925785Estimation of weights and validation: a marginal likelihood approach.Acta Crystallogr D Biol Crystallogr2003
12051905Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region.J Mol Biol2002
12009886The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.Biochemistry2002
11524374The Bioinformatics Template Library--generic components for biocomputing.Bioinformatics2001
11334886Tyrosine 331 and phenylalanine 334 in Clostridium perfringens alpha-toxin are essential for cytotoxic activity.FEBS Lett2001
10739917Rfree and the rfree ratio. II. Calculation Of the expected values and variances of cross-validation statistics in macromolecular least-squares refinement.Acta Crystallogr D Biol Crystallogr2000
11111911Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding.Int J Med Microbiol2000
11147832Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities.Arch Biochem Biophys2000
9761849Rfree and the rfree ratio. I. Derivation of expected values of cross-validation residuals used in macromolecular least-squares refinement.Acta Crystallogr D Biol Crystallogr1998
10089527Crystallization and preliminary X-ray diffraction studies of alpha-toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens.Acta Crystallogr D Biol Crystallogr1998
9699639Structure of the key toxin in gas gangrene.Nat Struct Biol1998
9761889Error estimates of protein structure coordinates and deviations from standard geometry by full-matrix refinement of gammaB- and betaB2-crystallin.Acta Crystallogr D Biol Crystallogr1998
7613869The avian eye lens protein delta-crystallin shows a novel packing arrangement of tetramers in a supramolecular helix.Structure1995
7721357An analysis of the antigen binding site of RT1.Aa suggests an allele-specific motif.Immunogenetics1995
7634077The structure of avian eye lens delta-crystallin reveals a new fold for a superfamily of oligomeric enzymes.Nat Struct Biol1994
8140092An algorithm for automatically generating protein topology cartoons.Protein Eng1994
  • 1 - 50 of 75

Recommended Authors

Incyte Corporation
Career Start Year 2000
Number of shared co-authors 0
Osaka university
Career Start Year 1998
Number of shared co-authors 2
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1997
Number of shared co-authors 2
Indian Institute of Science Education and Research Pune
Career Start Year 1996
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 1
Nankai University
Career Start Year 1995
Number of shared co-authors 1
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1990
Number of shared co-authors 3
University of Virginia
Career Start Year 1989
Number of shared co-authors 1
The Francis Crick Institute
Career Start Year 1989
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 1
Abo Akademi University
Career Start Year 1985
Number of shared co-authors 3
Cambridge Institute for Medical Research, University of Cambridge
Career Start Year 1982
Number of shared co-authors 1
Los Alamos National Laboratory
Career Start Year 1980
Number of shared co-authors 2
University of Oxford
Career Start Year 1976
Number of shared co-authors 3
Imperial College London
Career Start Year 1976
Number of shared co-authors 2
University of Milano
Career Start Year 1975
Number of shared co-authors 1
VIB-VUB Center for Structural Biology
Career Start Year 1975
Number of shared co-authors 2
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 1
Columbia University Irving Medical Center
Career Start Year 1971
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1971
Number of shared co-authors 3
Institute for Bioscience and Biotechnology Research
Career Start Year 1970
Number of shared co-authors 2
Stanford University
Career Start Year 1969
Number of shared co-authors 1
Columbia University
Career Start Year 1968
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 3
University of California berkeley
Career Start Year 1967
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 1
university of california los angeles
Career Start Year 1963
Number of shared co-authors 0
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 2

Collaborators

Heartand Lung Research Institute, University of Cambridge
Co-authored papers 7
Co-authored papers 3
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 2
Harwell Science & Innovation Campus
Co-authored papers 2
Rigshospitalet, University of Copenhagen
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
Center for Bioenergy, SASTRA Deemed University
Co-authored papers 1
University of Toronto
Co-authored papers 1
University College London
Co-authored papers 1
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1
University College London, Institute of Structural and Molecular Biology
Co-authored papers 1
University of Kent
Co-authored papers 1